Modified mosquitoes may reduce disease risks for humans, animals (vol 257, pg 874, 2020)

被引:0
|
作者
Garish, Brian
机构
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
引用
收藏
页码:984 / 984
页数:1
相关论文
共 18 条
  • [1] MODIFIED MOSQUITOES MAY REDUCE DISEASE RISKS FOR HUMANS, ANIMALS
    Cima, Greg
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2020, 257 (09): : 874 - 874
  • [2] Peanuts may reduce heart disease (vol 33, pg 13, 1997)
    不详
    CHEMISTRY IN BRITAIN, 1997, 33 (11) : 11 - 11
  • [3] Vitamin B may reduce risk of heart disease (vol 316, pg 498, 1998)
    Josefson, D
    BRITISH MEDICAL JOURNAL, 1998, 316 (7132): : 648 - 648
  • [4] Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases (vol 41, 874, 2020)
    Gal, Zsofia
    Gezsi, Andras
    Pallinger, Eva
    Visnovitz, Tamas
    Nagy, Adrienne
    Kiss, Andras
    Sultesz, Monika
    Csoma, Zsuzsanna
    Tamasi, Lilla
    Galffy, Gabriella
    Szalai, Csaba
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [5] Risks and benefits of unapproved disease-modifying treatments for neurodegenerative disease (vol 94, pg e1, 2020)
    Feustel, A. C.
    MacPherson, A.
    Fergusson, D. A.
    Kieburtz, K.
    Kimmelman, J.
    NEUROLOGY, 2020, 95 (15) : 708 - 708
  • [6] The association between chronic musculoskeletal pain and clinical outcome in chronic kidney disease patients: a prospective cohort study (vol 41, pg 257, 2020)
    Hsu, Heng-Jung
    Wu, I-Wen
    Hsu, Kuang-Hung
    Sun, Chiao-Yin
    Hung, Ming-Jui
    Chen, Chun-Yu
    Tsai, Chi-Jen
    Wu, Mai-Szu
    Lee, Chin-Chan
    RENAL FAILURE, 2020, 42 (01) : 304 - 304
  • [7] Huntingtin-Lowering Therapies for Huntington Disease: A Review of the Evidence of Potential Benefits and Risks (vol 57, pg 612, 2020)
    Leavitt, B. R.
    Kordasiewicz, H. B.
    Schobel, SA.
    JAMA NEUROLOGY, 2020, 77 (08) : 1040 - 1040
  • [8] RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice (vol 2, pg 1113, 2020)
    Karunakaran, Denuja
    Turner, Adam W.
    Duchez, Anne-Claire
    Soubeyrand, Sebastien
    Rasheed, Adil
    Smyth, David
    Cook, David P.
    Nikpay, Majid
    Kandiah, Joshua W.
    Pan, Calvin
    Geoffrion, Michele
    Lee, Richard
    Boytard, Ludovic
    Wyatt, Hailey
    Nguyen, My-Anh
    Lau, Paulina
    Laakso, Markku
    Ramkhelawon, Bhama
    Alvarez, Marcus
    Pietilainen, Kirsi H.
    Pajukanta, Paivi
    Vanderhyden, Barbara C.
    Liu, Peter
    Berger, Scott B.
    Gough, Peter J.
    Bertin, John
    Harper, Mary-Ellen
    Lusis, Aldons J.
    McPherson, Ruth
    Rayner, Katey J.
    NATURE METABOLISM, 2020, 2 (10) : 1181 - 1181
  • [9] What are the infectious risks with disease-modifying drugs for multiple sclerosis and how to reduce them? A review of literature' (vol 176, pg 235, 2019)
    Pourcher, V.
    REVUE NEUROLOGIQUE, 2020, 176 (06) : 526 - 526
  • [10] Tuberculosis: A modified quantiferon assay may help diagnose latent infection and hard-to-identify active disease (vol 124, pg 115, 2003)
    Yeager, H
    Zeligs, B
    Chavez, J
    Riazi, S
    Bellanti, JA
    CHEST, 2004, 125 (01) : 356 - 356